Page last updated: 2024-08-26

4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol and carbon monoxide

4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol has been researched along with carbon monoxide in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (37.50)29.6817
2010's4 (50.00)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Carmella, SG; Han, S; Hatsukami, DK; Hecht, SS; Joseph, AM; Le, CT; Murphy, SE; Zhang, Y1
Babb, D; Hatsukami, D; Hecht, S; LeSage, M; Mooney, M; Murphy, S1
Bliss, R; Carmella, SG; Gross, M; Hatsukami, DK; Hecht, SS; Joseph, AM; Lando, H; Le, CT; Murphy, SE1
Carmella, SG; Hatsukami, DK; Hecht, SS; Hertsgaard, LA; Jensen, JA; Kotlyar, M; Lindgren, BR; Murphy, SE; Stepanov, I1
Liang, Q; Mendes, P; Sarkar, M; Wang, J1
Dettbarn, G; Hahn, J; Luch, A; Schubert, J; Schulz, TG; Seidel, A1
Allen, SI; Azzouz, N; Cather, C; Evins, AE; Foulds, J; Hameed, A; Hammett, E; Hrabovsky, S; Krebs, NM; Liao, J; Modesto, J; Muscat, JE; Pachas, GN; Richie, J; Veldheer, S; Yingst, J; Zhu, J1
Ahluwalia, JS; Benowitz, NL; Nollen, NL; Pulvers, K; Qu, K; Rice, M; Schmid, CH1

Trials

4 trial(s) available for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol and carbon monoxide

ArticleYear
Smoking reduction fails to improve clinical and biological markers of cardiac disease: a randomized controlled trial.
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2008, Volume: 10, Issue:3

    Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Carbon Monoxide; Cotinine; F2-Isoprostanes; Female; Fibrinogen; Glucuronides; Heart Diseases; Humans; Male; Middle Aged; Nitrosamines; Pyrenes; Pyridines; Smoking; Smoking Cessation; Smoking Prevention

2008
Effect of oral snus and medicinal nicotine in smokers on toxicant exposure and withdrawal symptoms: a feasibility study.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2011, Volume: 20, Issue:1

    Topics: Adolescent; Adult; Aged; Carbon Monoxide; Cotinine; Feasibility Studies; Humans; Middle Aged; Nicotine; Nitrosamines; Pyridines; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco, Smokeless; Young Adult

2011
A two-site, two-arm, 34-week, double-blind, parallel-group, randomized controlled trial of reduced nicotine cigarettes in smokers with mood and/or anxiety disorders: trial design and protocol.
    BMC public health, 2017, 01-19, Volume: 17, Issue:1

    Topics: Adult; Anxiety Disorders; Biomarkers; Carbon Monoxide; Clinical Protocols; Cotinine; Double-Blind Method; Female; Humans; Male; Massachusetts; Mood Disorders; Nicotiana; Nicotine; Nicotinic Agonists; Nitrosamines; Oxidative Stress; Pennsylvania; Pyrenes; Pyridines; Smoke; Smoking; Smoking Cessation; Tobacco Products; Tobacco Use Disorder; United States; United States Food and Drug Administration; Young Adult

2017
Effect of Pod e-Cigarettes vs Cigarettes on Carcinogen Exposure Among African American and Latinx Smokers: A Randomized Clinical Trial.
    JAMA network open, 2020, 11-02, Volume: 3, Issue:11

    Topics: Adult; Black or African American; Blood Pressure; Breath Tests; Carbon Monoxide; Carcinogens; Cigarette Smoking; Cotinine; Electronic Nicotine Delivery Systems; Female; Harm Reduction; Hispanic or Latino; Humans; Male; Maximal Midexpiratory Flow Rate; Middle Aged; Nitrosamines; Tobacco Products; Vaping

2020

Other Studies

4 other study(ies) available for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol and carbon monoxide

ArticleYear
Relationships between cigarette consumption and biomarkers of tobacco toxin exposure.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2005, Volume: 14, Issue:12

    Topics: Biomarkers; Carbon Monoxide; Cotinine; Cross-Sectional Studies; Endpoint Determination; Female; Humans; Male; Middle Aged; Nitrosamines; Polycyclic Aromatic Hydrocarbons; Pyridines; Randomized Controlled Trials as Topic; Smoking; Urinalysis

2005
Effects of high dose transdermal nicotine replacement in cigarette smokers.
    Pharmacology, biochemistry, and behavior, 2007, Volume: 86, Issue:1

    Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Algorithms; Blood Pressure; Body Weight; Carbon Monoxide; Cotinine; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Leukocyte Count; Male; Middle Aged; Nicotine; Nicotinic Agonists; Nitrosamines; Pyridines; Smoking; Smoking Cessation

2007
Is 24h nicotine equivalents a surrogate for smoke exposure based on its relationship with other biomarkers of exposure?
    Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals, 2011, Volume: 16, Issue:2

    Topics: Acrolein; Adult; Benzene; Biomarkers; Butadienes; Carbon Monoxide; Environmental Exposure; Female; Humans; Male; Nicotiana; Nicotine; Nitrosamines; Pyrenes; Pyridines; Randomized Controlled Trials as Topic; Smoke; Smoking; Time Factors

2011
Mainstream smoke of the waterpipe: does this environmental matrix reveal as significant source of toxic compounds?
    Toxicology letters, 2011, Sep-10, Volume: 205, Issue:3

    Topics: Adult; Benzo(a)pyrene; Body Burden; Carbon Monoxide; Carboxyhemoglobin; Carcinogens; Cotinine; Glycerol; Humans; Hygroscopic Agents; Nicotiana; Nicotine; Nitrosamines; Polycyclic Aromatic Hydrocarbons; Propylene Glycol; Pyridines; Smoke; Smoking; Water

2011